ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

HSP

89.95
0.00 (0.00%)
16 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
NYSE:HSP NYSE Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 89.95 0.00 00:00:00

Statement of Changes in Beneficial Ownership (4)

03/09/2015 5:07pm

Edgar (US Regulatory)


FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Werner Thomas E
2. Issuer Name and Ticker or Trading Symbol

HOSPIRA INC [ HSP ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
SVP, Finance & CFO
(Last)          (First)          (Middle)

C/O HOSPIRA, INC., 275 NORTH FIELD DRIVE
3. Date of Earliest Transaction (MM/DD/YYYY)

9/3/2015
(Street)

LAKE FOREST, IL 60045
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   9/3/2015     M (1)    664.7404   A   (1) 664.7404   I   Phantom Shares held in deferred compensation plan  
Common Stock   9/3/2015     D    664.7404   D   (1) 0   I   Phantom Shares held in deferred compensation plan  
Common Stock   9/3/2015     A (2)    20243   A $0   109015   D    
Common Stock   9/3/2015     A (3)    11007   A $0   120022   D    
Common Stock   9/3/2015     A (4)    12066   A $0   132088   D    
Common Stock   9/3/2015     M (5)    20000   A $38.13   152088   D    
Common Stock   9/3/2015     M (6)    40541   A $49.64   192629   D    
Common Stock   9/3/2015     M (7)    6676   A $53.30   199305   D    
Common Stock   9/3/2015     M (8)    32531   A $52.61   231836   D    
Common Stock   9/3/2015     M (9)    69860   A $35.36   301696   D    
Common Stock   9/3/2015     M (10)    73171   A $28.95   374867   D    
Common Stock   9/3/2015     M (11)    53333   A $42.70   428200   D    
Common Stock   9/3/2015     D    428200   D $90.00   0   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (right to buy)   $38.13   9/3/2015     M         20000      (5) 9/28/2016   Common Stock   20000   $0   0   D    
Stock Options (right to buy)   $49.64   9/3/2015     M         40541      (6) 2/10/2017   Common Stock   40541   $0   0   D    
Stock Options (right to buy)   $53.30   9/3/2015     M         6676      (7) 8/17/2017   Common Stock   6676   $0   0   D    
Stock Options (right to buy)   $52.61   9/3/2015     M         32531      (8) 2/23/2018   Common Stock   32531   $0   0   D    
Stock Options (right to buy)   $35.36   9/3/2015     M         69860      (9) 2/28/2019   Common Stock   69860   $0   0   D    
Stock Options (right to buy)   $28.95   9/3/2015     M         73171      (10) 2/26/2020   Common Stock   73171   $0   0   D    
Stock Options (right to buy)   $42.70   9/3/2015     M         53333      (11) 2/25/2021   Common Stock   53333   $0   0   D    
Phantom Shares     (1) 9/3/2015     M         664.7404      (1)   (1) Common Stock   664.7404   $0   0   I   Phantom Shares held in non-qualified savings and investment plan  

Explanation of Responses:
( 1)  Conversion of phantom shares that were acquired under Hospira's Non-Qualified Savings and Investment Plan, a non-qualified deferred compensation plan. Each share of phantom stock is the economic equivalent of one share of common stock. The vested shares of phantom stock become payable in cash, based upon the account balance at the time of distribution upon the earlier of a date specified by the reporting person or upon a change in control.
( 2)  Vesting of performance share units for the 2013-2015 performance cycle. The award provided for vesting based on achievement of total shareholder return over a three year performance period relative to the performance of a pre-established peer group, or upon a change of control. Thus, the units vested on September 3, 2015.
( 3)  Vesting of performance share units for the 2014-2016 performance cycle. The award provided for vesting based on achievement of total shareholder return over a three year performance period relative to the performance of a pre-established peer group, or upon a change of control. Thus, the units vested on September 3, 2015.
( 4)  Vesting of a performance-contingent restricted stock units award granted February 27, 2013. The units were earned when Hospira's stock price appreciated 20% over the fair market value on the date of grant, and maintained that price for a 30 consecutive trading day period (based on Hospira's closing market price on those 30 consecutive days). Since the units were earned, the award provided for three-year time based cliff vesting, or upon a change of control. Thus, vesting of the units was accelerated upon a change of control.
( 5)  Exercise of stock options granted on 9/29/2006, which vested in four equal installments on September 29, 2007, 2008, 2009 and 2010. The stock options expire in ten years, or September 28, 2016.
( 6)  Exercise of stock options granted on 2/11/2010, which vested in three equal installments on February 11, 2011, 2012 and 2013.
( 7)  Exercise of stock options granted on 08/18/10, which vested in three equal installments on August 18, 2011, 2012 and 2013.
( 8)  Exercise of stock options granted on 2/24/2011, which vested in four equal installments on February 24, 2012, 2013, 2014 and 2015.
( 9)  Exercise of stock options granted on 3/1/2012, which vest in four equal installments on March 1, 2013, 2014, 2015, and 2016. The vesting of the last tranche of options was accelerated in connection with the change of control.
( 10)  Exercise of stock options granted on 2/27/2013, which vest in four annual installments on February 27, 2014, 2015, 2016 and 2017. The vesting of the last two tranches of options was accelerated in connection with the change of control.
( 11)  Exercise of stock options granted on 2/26/2014, which vest in four annual installments on February 26, 2015, 2016, 2017 and 2018. The vesting of the last three tranches of options was accelerated in connection with the change of control.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Werner Thomas E
C/O HOSPIRA, INC.
275 NORTH FIELD DRIVE
LAKE FOREST, IL 60045


SVP, Finance & CFO

Signatures
Koreen A. Ryan, Attorney in Fact 9/3/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

1 Year Hospira Chart

1 Year Hospira Chart

1 Month Hospira Chart

1 Month Hospira Chart

Your Recent History

Delayed Upgrade Clock